Elloxazinone B

Details

Top
Internal ID a33fad9b-5901-47c4-a359-3ec1e9debea3
Taxonomy Organoheterocyclic compounds > Benzoxazines > Phenoxazines
IUPAC Name 8-amino-9-carbamoyl-7-oxophenoxazine-2-carboxylic acid
SMILES (Canonical) C1=CC2=C(C=C1C(=O)O)N=C3C(=CC(=O)C(=C3C(=O)N)N)O2
SMILES (Isomeric) C1=CC2=C(C=C1C(=O)O)N=C3C(=CC(=O)C(=C3C(=O)N)N)O2
InChI InChI=1S/C14H9N3O5/c15-11-7(18)4-9-12(10(11)13(16)19)17-6-3-5(14(20)21)1-2-8(6)22-9/h1-4H,15H2,(H2,16,19)(H,20,21)
InChI Key KWCIFDPCOYGUFV-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H9N3O5
Molecular Weight 299.24 g/mol
Exact Mass 299.05422040 g/mol
Topological Polar Surface Area (TPSA) 145.00 Ų
XlogP 0.20
Atomic LogP (AlogP) 0.67
H-Bond Acceptor 6
H-Bond Donor 3
Rotatable Bonds 2

Synonyms

Top
8-amino-9-carbamoyl-7-oxophenoxazine-2-carboxylic acid

2D Structure

Top
2D Structure of Elloxazinone B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7273 72.73%
Caco-2 - 0.9069 90.69%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Mitochondria 0.3617 36.17%
OATP2B1 inhibitior - 0.5761 57.61%
OATP1B1 inhibitior + 0.9341 93.41%
OATP1B3 inhibitior + 0.9408 94.08%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.8062 80.62%
P-glycoprotein inhibitior - 0.8709 87.09%
P-glycoprotein substrate - 0.7689 76.89%
CYP3A4 substrate - 0.6074 60.74%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8809 88.09%
CYP3A4 inhibition - 0.8678 86.78%
CYP2C9 inhibition - 0.7253 72.53%
CYP2C19 inhibition - 0.7893 78.93%
CYP2D6 inhibition - 0.9381 93.81%
CYP1A2 inhibition + 0.6507 65.07%
CYP2C8 inhibition + 0.6459 64.59%
CYP inhibitory promiscuity - 0.8797 87.97%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8900 89.00%
Carcinogenicity (trinary) Non-required 0.6710 67.10%
Eye corrosion - 0.9947 99.47%
Eye irritation - 0.9439 94.39%
Skin irritation - 0.8552 85.52%
Skin corrosion - 0.9722 97.22%
Ames mutagenesis + 0.5700 57.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8451 84.51%
Micronuclear + 0.9300 93.00%
Hepatotoxicity + 0.7534 75.34%
skin sensitisation - 0.9047 90.47%
Respiratory toxicity + 0.6667 66.67%
Reproductive toxicity + 0.6444 64.44%
Mitochondrial toxicity + 0.6250 62.50%
Nephrotoxicity + 0.4878 48.78%
Acute Oral Toxicity (c) III 0.4929 49.29%
Estrogen receptor binding + 0.6235 62.35%
Androgen receptor binding + 0.8625 86.25%
Thyroid receptor binding - 0.5943 59.43%
Glucocorticoid receptor binding + 0.8699 86.99%
Aromatase binding + 0.6635 66.35%
PPAR gamma + 0.8420 84.20%
Honey bee toxicity - 0.9382 93.82%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.8500 85.00%
Fish aquatic toxicity - 0.6372 63.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1293294 P51151 Ras-related protein Rab-9A 98.30% 87.67%
CHEMBL1293277 O15118 Niemann-Pick C1 protein 96.97% 81.11%
CHEMBL1293249 Q13887 Kruppel-like factor 5 95.73% 86.33%
CHEMBL3864 Q06124 Protein-tyrosine phosphatase 2C 93.36% 94.42%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 91.23% 99.23%
CHEMBL1811 P34995 Prostanoid EP1 receptor 87.55% 95.71%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.63% 91.11%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 85.60% 90.71%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.74% 95.56%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 82.28% 94.00%
CHEMBL5284 Q96RR4 CaM-kinase kinase beta 82.15% 89.23%
CHEMBL4040 P28482 MAP kinase ERK2 81.78% 83.82%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 81.29% 93.04%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.82% 89.00%
CHEMBL3194 P02766 Transthyretin 80.24% 90.71%

Cross-Links

Top
PubChem 16658737
NPASS NPC139306
LOTUS LTS0033233
wikiData Q77568805